Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction

View ORCID ProfileJeremy Ratcliff, Farah Al-Beidh, View ORCID ProfileSagida Bibi, View ORCID ProfileDavid Bonsall, Sue Ann Costa Clemens, View ORCID ProfileLise Estcourt, Amy Evans, View ORCID ProfileMatthew Fish, View ORCID ProfilePedro M. Folegatti, View ORCID ProfileAnthony C. Gordon, Cecilia Jay, View ORCID ProfileAislinn Jennings, Emma Laing, View ORCID ProfileTeresa Lambe, George MacIntyre-Cockett, View ORCID ProfileDavid Menon, View ORCID ProfilePaul R. Mouncey, View ORCID ProfileDung Nguyen, View ORCID ProfileAndrew J. Pollard, Maheshi N. Ramasamy, View ORCID ProfileDavid J. Roberts, View ORCID ProfileKathryn M. Rowan, Jennifer Rynne, View ORCID ProfileManu Shankar-Hari, Sarah Williams, View ORCID ProfileHeli Harvala, View ORCID ProfileTanya Golubchik, View ORCID ProfilePeter Simmonds, the AMPHEUS Project, REMAP-CAP Immunoglobulin Domain UK Investigators, and Oxford COVID-19 Vaccine Trial Group
doi: https://doi.org/10.1101/2021.11.01.21265384
Jeremy Ratcliff
1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremy Ratcliff
  • For correspondence: jeremy.ratcliff@ndm.ox.ac.uk
Farah Al-Beidh
2Imperial College London, London, United Kingdom
3Imperial College Health NHS Trust, St. Mary’s Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagida Bibi
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sagida Bibi
David Bonsall
5Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Bonsall
Sue Ann Costa Clemens
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
6Institute of Global Health, University of Siena, Siena, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lise Estcourt
7Haematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
8Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lise Estcourt
Amy Evans
8Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Fish
9School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom
10Guy’s and St. Thomas’ NHS Foundation Trust, St. Thomas’ Hospital, London, United Kingdom
11Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew Fish
Pedro M. Folegatti
12Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pedro M. Folegatti
Anthony C. Gordon
2Imperial College London, London, United Kingdom
3Imperial College Health NHS Trust, St. Mary’s Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony C. Gordon
Cecilia Jay
1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aislinn Jennings
9School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom
10Guy’s and St. Thomas’ NHS Foundation Trust, St. Thomas’ Hospital, London, United Kingdom
11Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aislinn Jennings
Emma Laing
8Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Lambe
12Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Teresa Lambe
George MacIntyre-Cockett
5Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Menon
13University Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Menon
Paul R. Mouncey
14Intensive Care National Audit and Research Centre, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul R. Mouncey
Dung Nguyen
1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dung Nguyen
Andrew J. Pollard
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
15NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Pollard
Maheshi N. Ramasamy
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
16Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Roberts
7Haematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
17Clinical, Research, and Development, NHS Blood and Transport, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David J. Roberts
Kathryn M. Rowan
14Intensive Care National Audit and Research Centre, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn M. Rowan
Jennifer Rynne
9School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom
10Guy’s and St. Thomas’ NHS Foundation Trust, St. Thomas’ Hospital, London, United Kingdom
11Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manu Shankar-Hari
9School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom
10Guy’s and St. Thomas’ NHS Foundation Trust, St. Thomas’ Hospital, London, United Kingdom
11Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manu Shankar-Hari
Sarah Williams
1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
16Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heli Harvala
18Microbiology Services, NHS Blood and Transport, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heli Harvala
Tanya Golubchik
5Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tanya Golubchik
Peter Simmonds
1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Simmonds
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Tools to detect SARS-Coronavirus-2 variants of concern and track the ongoing evolution of the virus are necessary to support public health efforts and the design and evaluation of novel COVID-19 therapeutics and vaccines. Although next-generation sequencing (NGS) has been adopted as the gold standard method for discriminating SARS-CoV-2 lineages, alternative methods may be required when processing samples with low viral loads or low RNA quality.

Methods An allele-specific probe polymerase chain reaction (ASP-PCR) targeting lineage-specific single nucleotide polymorphisms (SNPs) was developed and used to screen 1,082 samples from two clinical trials in the United Kingdom and Brazil. Probit regression models were developed to compare ASP-PCR performance against 1,771 NGS results for the same cohorts.

Results Individual SNPs were shown to readily identify specific variants of concern. ASP-PCR was shown to discriminate SARS-CoV-2 lineages with a higher likelihood than NGS over a wide range of viral loads. Comparative advantage for ASP-PCR over NGS was most pronounced in samples with Ct values between 26-30 and in samples that showed evidence of degradation. Results for samples screened by ASP-PCR and NGS showed 99% concordant results.

Discussion ASP-PCR is well-suited to augment but not replace NGS. The method can differentiate SARS-COV-2 lineages with high accuracy and would be best deployed to screen samples with lower viral loads or that may suffer from degradation. Future work should investigate further destabilization from primer:target base mismatch through altered oligonucleotide chemistry or chemical additives.

Competing Interest Statement

Oxford University has entered into a partnership with AstraZeneca for further development of ChAd-Ox1 nCoV-19. AstraZeneca did not have a role in reviewing the data for this study.

Clinical Trial

NCT02735707 (REMAP-CAP) NCT04536051 (COV003)

Funding Statement

The COV003 trial is supported by the National Institute of Health Research (NIHR), the Lemann Foundation, Rede D'Or, the Brava and Telles Foundation, and AstraZeneca. The REMAP-CAP trial is supported by The Platform for European Preparedness Against (Re-) emerging Epidemics (PREPARE) consortium by the European Union, FP7-HEALTH-2013-INNOVATION-1 (#602525), the Australian National Health and Medical Research Council (#APP1101719), the Australian Medical Research Future Fund (#APP2002132), the New Zealand Health Research Council (#16/631), the Canadian Institutes of Health Research COVID-19 Rapid Research Funding Grant (#447335), the Canadian Institute of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program Grant (#158584), the National Institute for Health Research (UKRIDHSC COVID-19 Rapid Response Rolling Call, "The use of convalescent plasma to treat hospitalised and critically ill patients with COVID-19 disease" (COV19- RECPLAS), the UK National Institute for Health Research (NIHR) and the NIHR Imperial Biomedical Research Centre, the Health Research Board of Ireland (CTN 2014-012), the UPMC Learning While Doing Program, the Translational Breast Cancer Research Consortium, the Pittsburgh Foundation, the French Ministry of Health (PHRC-20-0147), the Minderoo Foundation, and the Wellcome Trust Innovations Project (215522). Australian governments fund Australian Red Cross Lifeblood for the provision of blood products and services to Australia. Collection of UK plasma was funded by the DHSC through core funding under COVID-19 and EU SoHo Grants.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

REMAP-CAP was performed in accordance with regulatory and legal requirements (EudraCT number: 2015-002340-14) and was approved by London-Surrey Borders Research Ethics Committee London Centre (18/LO/0660). COV003 was approved by the Brazilian National Research Ethics Committee (ref: 32604920.5.0000.5505) and the Oxford Tropical Research Ethics Committee (ref: 20-36).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted November 02, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
Jeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, David Bonsall, Sue Ann Costa Clemens, Lise Estcourt, Amy Evans, Matthew Fish, Pedro M. Folegatti, Anthony C. Gordon, Cecilia Jay, Aislinn Jennings, Emma Laing, Teresa Lambe, George MacIntyre-Cockett, David Menon, Paul R. Mouncey, Dung Nguyen, Andrew J. Pollard, Maheshi N. Ramasamy, David J. Roberts, Kathryn M. Rowan, Jennifer Rynne, Manu Shankar-Hari, Sarah Williams, Heli Harvala, Tanya Golubchik, Peter Simmonds, the AMPHEUS Project, REMAP-CAP Immunoglobulin Domain UK Investigators, and Oxford COVID-19 Vaccine Trial Group
medRxiv 2021.11.01.21265384; doi: https://doi.org/10.1101/2021.11.01.21265384
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
Jeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, David Bonsall, Sue Ann Costa Clemens, Lise Estcourt, Amy Evans, Matthew Fish, Pedro M. Folegatti, Anthony C. Gordon, Cecilia Jay, Aislinn Jennings, Emma Laing, Teresa Lambe, George MacIntyre-Cockett, David Menon, Paul R. Mouncey, Dung Nguyen, Andrew J. Pollard, Maheshi N. Ramasamy, David J. Roberts, Kathryn M. Rowan, Jennifer Rynne, Manu Shankar-Hari, Sarah Williams, Heli Harvala, Tanya Golubchik, Peter Simmonds, the AMPHEUS Project, REMAP-CAP Immunoglobulin Domain UK Investigators, and Oxford COVID-19 Vaccine Trial Group
medRxiv 2021.11.01.21265384; doi: https://doi.org/10.1101/2021.11.01.21265384

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (416)
  • Anesthesia (93)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (398)
  • Epidemiology (8597)
  • Forensic Medicine (4)
  • Gastroenterology (391)
  • Genetic and Genomic Medicine (1774)
  • Geriatric Medicine (170)
  • Health Economics (375)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (198)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10354)
  • Intensive Care and Critical Care Medicine (554)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (934)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (256)
  • Pediatrics (541)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1788)
  • Public and Global Health (3877)
  • Radiology and Imaging (629)
  • Rehabilitation Medicine and Physical Therapy (324)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (171)
  • Sports Medicine (159)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)